Professor Aki Tsuchiya
PhD (Kyoto)
Population Health, School of Medicine and Population Health
School of Economics
Professor of Health Economics
+44 114 222 3422
Full contact details
Population Health, School of Medicine and Population Health
9 Mappin Street
91直播
S1 4DT
- Profile
-
I came to the UK in 1998 as a Visiting Research Fellow at the Centre for Health Economics, University of York, funded as an Overseas Postdoctoral Research Fellow of the Japan Society for the Promotion of Science. I came to the University of 91直播 and joined what was then the School of Health and Related Research (ScHARR; now Division of Population Health) in 2000, where I worked as a Research Associate, a Research Fellow, and a Lecturer. Since 2005, I have held a joint appointment between the School of Economics and ScHARR, as a Senior Lecturer, a Reader, and a Professor.
- Research interests
-
- Eliciting and modelling preferences for health, and other aspects of wellbeing
- Incorporating distributional concerns into social welfare functions
- Normative economics of health and beyond
I am interested in supervising PhD students in normative issues related to resource allocation and priority setting in health and wellbeing.
Current projects
- SIPHER (System-science Informed Public Health and Economic Research for Non-communicable Disease prevention)
- Policy Modelling for Health (HealthMod): 2024-2028
- Economic Methods of Evaluation in Health & Care Interventions (EEPRU III): 2024-2028
- Publications
-
Journal articles
- . Health Economics.
- . Social Science and Medicine, 315.
- . Value in Health, 25(4), 482-491.
- . Integrated Healthcare Journal, 4(1), 1-18.
- . Social Science & Medicine.
- . Health and Quality of Life Outcomes, 19.
- . European Journal of Health Economics.
- . Health Economics.
- . Medical Decision Making.
- . Health Economics, 27(8), 1247-1263.
- . Medical Decision Making, 37(6), 635-646.
- . Social Science & Medicine, 124, 48-56.
- Is more health always better for society? Exploring public preferences that violate monotonicity.. Theory and Decision.
- . HEALTH ECON, 20(3), 348-361.
- . Applied Economics, 43(18), 2241-2250.
- . Health Econ, 18(2), 147-159.
- . J HEALTH ECON, 28(1), 210-220.
- . J MED ETHICS, 34(7).
- . Soc Sci Med, 60(2), 277-286.
- . J HEALTH ECON, 23(2), 313-329.
- . Soc Sci Med, 57(4), 687-696.
- QALYs and ageism: philosophical theories and age weighting.. Health Econ, 9(1), 57-68.
- Predictors of becoming NEET: a dynamic comparison of the direct and indirect determinants. Journal of the Royal Statistical Society. Series A (General).
- Should we consider including a value for 鈥榟ope鈥 as an additional benefit within HTA?. Value in Health.
Reports
- . Health Economics.
- Teaching interests
-
- Health economics for economists
- Valuation of health states
- Normative health economics
I teach health economics, which is about the application of economic concepts to matters of health, healthcare, and healthcare insurance. But, to what extent can we apply economic reasoning to matters of life and limb? Some think that whenever somebody鈥檚 life is at stake, it is unethical to think of costs or money, and thus 鈥渉ealth鈥 and 鈥渆conomics鈥 sit very awkwardly with each other. However, if we ignore opportunity costs, then efficiency would be compromised and we would achieve less health overall. At the same time, most of us want a health care system that is not just efficient, but also equitable. Health economics enables the analysis of health care systems in the light of efficiency, equity, or both.
In health economics, there are numerous issues that involve value judgements, with no easy right answers. Should we use monetary valuation of health to analyse the efficiency of different drugs? Should health policy aim to maximise health or to maximise more general wellbeing? Should we forego any efficiency in order to improve equity in health outcomes? My approach to teaching is to encourage students to take an informed view on such issues, and then to defend these views (which may not agree with mine!).